Cytocell Ltd Introduces Direct Sales and Distribution for the United Kingdom

Cytocell Ltd Introduces Direct Sales and Distribution for the United Kingdom

English
2 Pages
Read
Download
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

Cytocell Ltd Introduces Direct Sales and Distribution for the United Kingdom PR Newswire CAMBRIDGE, England, September 6, 2012 CAMBRIDGE, England, September 6, 2012 /PRNewswire/ -- - Change in Cytocell's UK Distribution Cytocell Ltd

Subjects

Informations

Published by
Reads 14
Language English
Report a problem
Cytocell Ltd Introduces Direct Sales and Distribution for the United Kingdom
PR Newswire CAMBRIDGE, England, September 6, 2012
CAMBRIDGE, England,September 6, 2012/PRNewswire/ --
- Change in Cytocell's UK Distribution
Cytocell Ltd. a leading manufacturer of Human DNA FISH probes announced today that with immediate effect the supply of all Cytocell products within the United Kingdomwill revert from Labtech International Ltd back to Cytocell Ltd.
Labtech Ltd has successfully distributed the extensive Cytocell product ranges within the UK for the last two years. However, due to changes in strategic focus by both companies we have jointly decided that Cytocell will now directly distribute their products within the UK. Dr Martin Lawrie, Managing Director of Cytocell stated, "Following an extensive review Cytocell Ltd has decided to strengthen its supply chain arrangements for st theUnited Kingdom. The new arrangement takes effect from the 1 September 2012. We believe that this new arrangement will result in a more efficient supply chain whilst retaining high levels of service to our UK customers. Additionally, we welcome the opportunity to meet our UK customers' needs more efficiently ® through the use of highly successful myProbescustom FISH probe service."
About Cytocell Ltd.
Cytocell is a leading European developer and manufacturer of FISH probes for use in both routine cytogenetics and in the analysis and classification of Cancers. The Company's products are well established in Cytogenetics as the th Company is celebrating its 20year of supplying them to this market. More
recently, the Company has focused on developing products for Oncology and now has a catalogue of some 350 products for Cytogenetics, Haematology and Solid Tumour analysis as well as developing custom FISH probes for customers ® with specific interests under the myProbesbrand. Cytocell's products are available through a well established distributor network, covering more than 60 countries worldwide. Cytocell's FISH probe service is currently proving to be invaluable to cancer researchers and clinicians worldwide. Cytocell's news releases and other information are available on the company's Web site at http://www.cytocell.com. For further enquiries, please contact: Stewart Kennedy, Tel: +44-7860-455527 Sales & Marketing Director